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Trauma is a global public health problem and a leading source of the world’s burden of disease. 1-3 A 
critical complication following trauma haemorrhage is the early development of deranged 
coagulation.4 Patients that develop trauma-induced coagulopathy (TIC) have worse outcomes, with 
significantly higher rates of organ dysfunction, sepsis and mortality. 4-6 Furthermore, this patient 
group place considerable demand on hospital resources with greater blood transfusion and ventilator 
requirements, and longer critical care and hospital length of stay. 7, 8 
 
Early and aggressive resuscitation strategies that directly target TIC are associated with improved 
outcomes. 9-14 These “damage control” strategies include early empiric transfusion of whole blood or 
balanced ratios of blood products (1:1:1 for units of plasma to platelets to red blood cells) 14, 15, 
permissive hypotension 16, rapid haemorrhage control with abbreviated surgical procedures10, and 
early administration of plasma 17, cryoprecipitate 18 and tranexamic acid 9. While these interventions 
improve survival in patients at risk of TIC, they may cause significant harm and waste precious 
resources if used in the majority of injured patients with normal coagulation. 19-21 Early identification 
of TIC is, therefore, key to effective initiation of damage control interventions.22 23 However, rapid 
identification of at-risk patients can be challenging. Conventional coagulation tests have limited 
accuracy in trauma, and results are not available in a clinically useful timeframe to guide therapy. 24, 25 
Existing prediction models are also not accurate enough to reliably inform treatment decisions.26 
Viscoelastic haemostatic assays are better able to diagnose TIC and can provide results within a few 
minutes of blood draw 24, 27, but these complex devices are expensive, problematic for use in an 
emergency setting, and are unlikely to be routinely available worldwide. Current practice, therefore, 
relies on clinical judgement, which although rapid, is prone to error in the emergency setting 28, 29; or 
blind, unguided protocols, which preclude the tailoring of decisions to individual patient needs.  
 
Advances in machine learning, together with the availability of high-quality patient datasets, provide 
the opportunity to develop robust risk prediction algorithms that could be used to support early and 
tailored therapeutic decisions.30, 31 Accordingly, this study aimed to develop and validate a prediction 
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model that can provide clinicians with an early and accurate estimate of an injured patient’s risk of 






We developed a multivariable risk prediction model using a supervised machine learning method that 
combined domain knowledge and data from patients enrolled in the Activation of Coagulation & 
Inflammation in Trauma (ACIT) study. The development cohort comprised data from consecutive 
patients enrolled in the ACIT study between January 2007 and October 2011 at the Royal London 
Hospital. Performance was validated in new patients enrolled into the ACIT study following 
completion of model development (November 2011 to January 2014) at the Royal London Hospital 
(Temporal validation cohort) and two independent centres (External validation cohort): John 
Radcliffe Hospital, Oxford, UK, and the Cologne-Merheim Medical Centre, Cologne, Germany. The 
study is reported according to the Transparent Reporting of a multivariable prediction model for 
Individual Prognosis Or Diagnosis (TRIPOD) statement.32 
 
Sources of information 
Domain knowledge 
Domain knowledge on the causal mechanisms of TIC was identified by an electronic search of the 
MEDLINE and Embase databases using a combination of the terms “trauma” and “coagulopathy”. 
Relevant original studies, review articles, and clinical guidelines were considered. The reference lists 
of relevant articles were reviewed to identify additional publications. A structured framework is used 
to organise and present the evidence and knowledge that underpins each part of the model. 33 
 
Cohort study 
ACIT is a multi-national, prospective cohort study designed to identify the mechanisms by which the 
body’s coagulation pathways are activated immediately following injury.34 Adult patients (>15 years) 
presenting directly to participating Major Trauma Centres, who meet local criteria for trauma team 
activation, are included. Exclusion criteria include: arrival in the emergency department > 2 hours 
after injury; prehospital administration of > 2000ml intravenous fluid; and burns covering > 5% of 
body surface area. Patients are retrospectively excluded if they decline consent, take anticoagulation 
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medication, have moderate or severe liver disease, or a bleeding diathesis. The study was reviewed 
and approved by the National Research Ethics Committee of participating countries and written 
informed consent was obtained for all participants. 
 
Data collection 
Data were collected prospectively on patient demographics, injury characteristics, admission vital 
signs, treatment administered, and outcome. Blood samples were collected immediately on hospital 
arrival and used for standard laboratory coagulation tests, rotational thromboelastometry (ROTEM, 
TEM Innovations, Munich Germany), and blood gas analysis. Injuries were classified according to the 
2005 Abbreviated Injury Scale (AIS) and Injury Severity Score (ISS) by certified coders.35 All 
patients were followed-up daily until hospital discharge or death. 
 
Prediction outcome  
The model was designed to predict the risk of developing clinically relevant TIC. As standard 
coagulation tests have limitations in diagnosing TIC 24, 26, a systematic approach was used to classify 
each patient’s coagulation status into normal or TIC. First, all patients were classified according to the 
clinically accepted laboratory definition of TIC, an admission Prothrombin Time ratio (PTr) > 1.2. 36 
Second, all patients were independently clustered into normal or abnormal coagulation, based on the 
their clinical, laboratory, and thromboelastometry profile, using an expectation-maximisation (EM) 
algorithm.37 Third, cases where laboratory and machine-learning methods agreed were assigned the 
corresponding coagulation state as their final classification. Finally, cases where the two methods 
disagreed, or the PTr sample had haemolysed, underwent expert review to determine a final 
classification. Two TIC experts independently reviewed the clinical, laboratory, and 
thromboelastometry data of each discrepant case. Disagreement was resolved by consensus with a 
third expert. Experts were blind to the EM algorithm result and structure of the predictive model. 
Inter-reviewer agreement was evaluated with the kappa-statistic and expert consistency was evaluated 
in a random sample of 50 patients with known coagulation status. 
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Clinical relevance of outcome 
The clinical relevance of TIC was assessed in terms of mortality, transfusion requirements, Damage 
Control Surgery (DCS) requirements, and duration of ICU and hospital admission. Massive 
transfusion was defined as ≥ 10 units of blood transfused in 24 hours.38 DCS was defined as 
immediate resuscitative surgery aimed at controlling active haemorrhage and restoring normal 
physiology. DCS procedures included resuscitative thoracotomy, emergency laparotomy, extra-
peritoneal pelvic packing, temporary vascular shunts, and primary (life-saving) amputations; but 
excluded emergency craniotomy, exploratory laparotomy in patients’ with normal physiology, wound 
debridement, and definitive fracture fixation. 
 
Model development 
The algorithm is a Bayesian Network (BN). BNs consist of two parts: a network structure that 
graphically describes the models’ variables and their relations, and a set of parameters that captures 
the strength of the relationships between variables.39 The network structure was learned from domain 
knowledge and the parameters were learned from ACIT data. Our method follows an iterative, step-
wise, supervised machine-learning approach that has previously been described 37, and is summarised 
below: 
 
Step 1) Causal structure 
The BN structure was learned from domain knowledge. This enabled an evidence-based structure 
consistent with current understanding of the causal mechanisms of TIC to be developed. Domain 
knowledge informed the choice of variables, relationships between variables, and states that each 
variable can take. Where required, latent (unobserved) variables were introduced to model important 
intermediate mechanistic steps.37 Logical and physiological constraints, defined by clinical 
knowledge, were applied to variables. 
 
Step 2) Predictors 
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Potential predictors were identified from domain knowledge and limited to information that is 
available at the time the model is intended for use – during the initial patient assessment (primary 
survey). Continuous predictors were not catagorised and data-driven methods of selecting predictors 
were not used. Predictors were measured on admission by ACIT investigators prior to knowledge of 
the participant’s outcome. 
 
Step3) Parameter learning 
In a BN, the strength of the relationship between variables is defined by a conditional probability 
distribution (CPD). The CPD of each of the relations determined in Step 1 were learned from the 
ACIT development dataset using an Expectation-Maximisation (EM) algorithm.40 37  
 
Step 4) Internal validation and model refinement 
Prognostic performance was estimated by ten-fold cross validation in the development dataset.41 
Cases with inaccurate predictions were identified and underwent expert review. As the BN is 
compatible with domain knowledge, the reasoning mechanisms can be described, and inaccurate 
predictions can offer valuable lessons for model refinement. Possible causes of inaccuracies were 
investigated to identify 1) potential opportunities to improve the models structure, 2) data errors, and 
3) limitations in the models scope. Where opportunities to improve the model were identified, the 
development process returned to Step 1, with any changes supported by evidence. Where potential 
data errors were identified, the original sources were examined to verify data accuracy. Limitations to 
the scope of the model were documented and are presented in the discussion section. 
 
External validation and performance measures 
The trained BN generates a continuous number between 0 and 1 that corresponds to the probability of 
developing TIC. Performance in new participants was assessed in the temporal and external validation 
cohorts. Predictor information, recorded by ACIT investigators during the primary survey, was 
entered into the model. No imputation was performed for unknown variables. Performance was 
assessed in terms of discrimination, calibration, and accuracy. Discrimination was measured using the 
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Area Under the Receiver Operating Characteristic curve (AUROC). Calibration was evaluated with 
the Hosmer-Lemeshow test and graphically using a calibration plot of observed against predicted 
values.42 Accuracy was evaluated with the Brier Score (BS) and the Brier Skill Score (BSS). 43, 44 The 
BS has a value between 0 (perfect model) and 1 (worst possible model) and the BSS has a range from 
- ∞ to 1, where a negative value indicates a worse prediction than the average probability, and 1 
indicates a perfect model.  
 
Sensitivity analyses 
We assessed the impact that each predictor variable has on the model’s probability calculations using 
one-way sensitivity analyses. Second, we compared the model’s performance to that of each 
individual predictor included in the model. Finally, we assessed the BN’s sensitivity to missing 
information in the combined validation cohort (temporal and external) by comparing overall 
performance to performance when each predictor variable, in turn, was omitted as an input. 
 
Statistical analysis  
Statistical analyses of the results were performed using GraphPad PRISM v6 (GraphPad Software 
Inc., San Diego, CA, USA) and R statistical software (version 2.15.2). The BN was developed with, 
and is computed by, AgenaRisk software (Agena, London, UK). Numerical data are reported as 
median with interquartile range (IQR) and categorical data as frequency (n) and percentage (%). The 
Mann–Whitney U test was used to compare numerical data and Fisher’s Exact test was used to 
compare categorical data. Outcome comparisons between groups are reported as Relative Risk (RR) 
with corresponding 95% Confidence Intervals (CI). Time from injury to death between groups was 
compared with the log-rank (Mantel-Cox) test, and results presented as Kaplan-Meier curves. 
AUROC was calculated and compared using the method described by Hanley and McNeil. 45 The area 
under correlated ROC curves was compared using a non-parametric method that accounts for the 




The study population comprised 1091 injured patients, with 600 patients in the development cohort 
and 491 patients in the validation cohorts. Their median age was 37 (range: 15 - 95) years, 873 
(80.0%) were male, and 890 (81.6%) suffered a blunt mechanism of injury. The median time from 
injury to hospital admission was 76 (58 – 95) minutes. Baseline characteristics of the development 
and validation cohorts are presented in Table 1. Overall, 124 (11.4%) patients developed TIC. 
Characteristics of patients who developed TIC were significantly different to those with normal 
coagulation (SDC Table 1). With the exception of admission body temperature, missing data for 
clinical variables was minimal (Table 1). 
 
Outcome classification 
TIC classification was achieved by agreement between laboratory and EM methods in 978 (89.6%) 
patients and by expert review in the remaining 113 (10.4%) patients. The reasons for expert review 
were 1) no available PTr result due to haemolysis of the blood sample (66 cases, 6.1%) and 2) a 
discrepancy between the laboratory and EM classification (47 cases, 4.3%). Inter-reviewer agreement 
was excellent (κ = 0.94 [95% CI: 0.88 – 1.0]) and expert consistency was perfect. 
 
Clinical relevance of TIC 
Patients that developed TIC had substantially worse outcomes than those with normal coagulation 
(Table 2). Overall, patients that developed TIC were ten times more likely to die than those with 
normal coagulation, and the majority of deaths in coagulopathic patients occurred soon after injury 
(SDC Figure 1). Blood transfusion requirements, DCS requirements, ICU and hospital length of stay 
were all significantly greater in patients that developed TIC, compared to those with normal 




Domain knowledge describes five potential causes of TIC: tissue hypoperfusion, tissue injury, 
acidaemia, hypothermia, and haemodilution. These causal factors, and the relationships between 
them, formed the core structure of the prognostic model (Figure 1). Domain knowledge also describes 
several potential predictors for these causal mechanisms, which would be available during a standard 
primary survey. Fourteen predictor variables were incorporated in the final model and are defined in 
Table 3. The relationships between predictor variables, causal variables, and TIC are represented by 
the structure of the BN (Figure 2). Full details of the evidence supporting the BN’s structure are 




The BN had excellent predictive performance in the development cohort (AUROC 0.93 (95% CI: 
0.90 to 0.95)). The predicted risk of TIC calibrated well with observed outcomes (Figure 2A) and the 
Hosmer-Lemeshow goodness-of-fit test result was non-significant (P = 0.32). The BN’s predictions 
were accurate, with a Brier Score of 0.06 (95% CI: 0.05 – 0.08) and a Brier Skill Score of 0.40 (95% 
CI: 0.30 – 0.51). All predictor variables contributed to the BN’s performance (SDC Figure 2). 
Continuous variables related to hypoperfusion – specifically blood gas variables (Base Deficit, 
Lactate, pH), systolic blood pressure and heart rate – had the greatest impact on the model’s result. 
 
External Validation 
The BN’s performance in new populations matched the performance in the development cohort 
(Figure 2 and Table 4). AUROC was 0.96 (95% CI: 0.94 – 0.99) in the temporal validation cohort, 
and 0.93 (95% CI: 0.85 – 1.0) in the external validation cohort (Figure 2C). The model remained 




The BN was a better predictor of TIC than any individual variable in the model (SDC Figure 3 and 4). 
Omission of each predictor in turn from the models inputs did not have any significant effect on 
overall prognostic performance (Figure 2D). Indeed, the omission of all blood gas variable inputs, the 
three strongest individual predictors, had minimal effect on the BN’s performance (overall 
performance: AUROC 0.95 (0.93 - 0.98) versus performance without blood gas information: AUROC 
0.94 (0.91 – 0.98); P = 0.286).  
 
Model presentation 
The BN is available at http://www.traumamodels.com. Entering predictor variable values allows the 





Injured patients that present to hospital with trauma-induced coagulopathy (TIC) can be difficult to 
identify, but are responsible for almost all early trauma deaths, and require immediate, resource 
intense, resuscitative interventions. This study validates the clinical relevance of TIC, and describes 
the development and validation of a predictive model that enables early and accurate estimation of the 
risk of TIC in an injured patient.  
The findings of this study have some important implications for trauma care. The model’s outputs 
could be used to guide and support rational decisions on the effective activation and implementation 
of damage control resuscitation and surgery.  Early identification of high-risk patients, potentially 
prior to hospital arrival, could be used to objectively activate in-hospital pathways and protocols, 
thereby minimising logistic delays in the provision of critical interventions such as blood component 
transfusions, emergency surgery, and interventional radiology. On a wider scale the model has the 
potential to underpin quality assurance within trauma systems e.g. audit of major haemorrhage 
protocol activations and damage control decisions, in addition to patient stratification in clinical trials 
to select at risk populations most likely to benefit from novel therapies for TIC. 
 
Three models have previously been developed to identify patients with TIC.47-49 Cosgriff and 
colleagues derived a simple score using four binary predictors (systolic blood pressure < 70mmHg, 
temperature < 34 °C, pH <7.1, and ISS > 25), and suggest that their score may assist damage control 
surgery decision-making. 47  A critical limitation of this score is that one of the variables, ISS, is 
unknown when the score is intended for use. More recently, two scores have been developed to 
predict TIC using prehospital information.48, 49 Mitra and colleagues score uses five predictors that are 
all available during the early phase of care (entrapment; systolic blood pressure < 100mmHg; 
temperature < 35 °C; suspected abdominal or pelvic injury; and chest decompression), while Peltan 
and colleagues score uses six predictors (age, injury mechanism, prehospital shock index ≥1, Glasgow 
Coma Score, and need for prehospital tracheal intubation and/or CPR. 48, 49 Both scores achieved only 
moderate performance in new patients, with sensitivity less than 30% when operated at the 
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recommended thresholds.49 Although these scores demonstrate that TIC is predictable from clinical 
information, none are accurate enough to reliably support clinical decision-making.26 The moderate 
performance may be the result of a number of methodological limitations (Table 5). First, simple 
scores may not be sufficiently powerful to accurately predict complex pathophysiological processes. 
Second, by limiting the number of predictors and dichotomising continuous variables, much of the 
prognostic potential of available information is lost.50, 51 Finally, although developed to predict 
patients with TIC, these scores actually predict a laboratory test result, and using an imperfect 
surrogate outcome may limit the clinical relevance of the score. 52  
 
The findings of this study have implications for methodology used to develop prognostic models for 
use in other emergency settings. Our results support the use of domain knowledge to reduce over-
fitting and develop evidence-based models with better generalisability. An advantage of Bayesian 
networks is that they provide a platform that facilitates the incorporation of a broad range of evidence, 
not just data, in model development. 37, 39 Furthermore, we have shown that Bayesian networks can 
produce robust models that are able to use a variable selection of predictor information, and capable 
of handling missing or uncertain information. This is likely to be a meaningful advantage in 
emergency settings, and overcomes a major limitation of traditional prognostic models, which require 
accurate and complete predictor information to function. 39 
 
The scope of our model may be limited in certain circumstances. First, although the models structure 
was learned from knowledge, the parameters were learned from data. The ACIT study provides an 
optimal source of data for developing a TIC prediction model. However, certain study exclusions 
applied, and the model may not be accurate in these populations. Patients on anticoagulation 
medication or with significant liver disease were excluded, and the model is not designed to predict 
coagulation abnormalities resulting from these causes. Patients who could not be recruited within two 
hours of injury were also excluded. Although the model includes predictors for all known causes of 
TIC, accuracy may be affected following prolonged periods of resuscitation. Haemodilution is an 
important iatrogenic cause of TIC but patients administered more than two litres of prehospital fluid 
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were excluded from ACIT. Published evidence was used to learn the relationship for higher volumes8, 
however, accuracy in these circumstances has not been validated.  
Second, during development, subgroups of injured patients in which the model performed less well 
were identified. Although the model accurately predicts coagulopathy in the majority of patients with 
a head injury, it underestimates the degree of coagulopathy in patients with catastrophic head injuries 
(Head AIS≥5, extensive intracranial bleed, brain herniation). Indeed, patients with catastrophic head 
injuries, and no evidence of major extracranial injury, account for over 80% of false negative 
predictions. The mechanisms of coagulopathy following traumatic brain injury are uncertain.53 As the 
model is derived from existing knowledge, the incomplete understanding of the causes of 
coagulopathy in patients with isolated severe brain injuries is reflected in the model’s performance in 
this subgroup of injured patients.  Finally, patients who suffered an assault, with a relatively minor 
injury, but presented with a marked metabolic acidosis following extreme physical exertion, also 
resulted in some inaccurate predictions (false positive). In these patients the model was unable to 
accurately differentiate the acute physiological changes resulting from decreased oxygen delivery in 
compensated haemorrhagic shock from those caused by increased oxygen requirements following 
extreme physical exertion.  
 
This study has some limitations. First, a BN’s predictive performance depends on how accurately its 
structure and parameters approximate reality. Our BN’s structure was informed by existing 
knowledge. However, our current understanding of the causes and mechanisms of traumatic 
coagulopathy is not complete. This may explain the model’s underperformance in certain subgroups, 
such as patients with catastrophic head injuries, where knowledge of the mechanism of coagulopathy 
is weak. The excellent performance in the majority of injured patients, however, provides evidence 
that existing knowledge of the key causes of TIC is reliable. Network parameters were learned from 
data, which was collected in a standardised way as part of a prospective observational study 
investigating TIC. This represents the optimal source of data for developing a prognostic model, as it 
limits missing data and information bias. However, one variable (temperature) had a large amount of 




Second, the model’s performance was validated in a civilian trauma population, where all patients 
were treated in well-resourced specialist trauma centres and therefore its performance in military 
casualties or less well-resourced settings is not known. Third, the model is designed to enable early 
identification of coagulopathy risk to support rapid activation of targeted haemostatic interventions. 
The model was not designed to measure the response of the coagulation system to these interventions, 
and has not been validated for this purpose. Near-patient tests, such as thromboelastography, are able 
to describe specific coagulation function defects, and may be better suited to assess the response to 
therapy and tailor damage control interventions accordingly. 54 Last, although the Bayesian network 
provides fundamental information to support rational damage control decisions, the impact of this 
information on decision-making, and ultimately patient outcomes, has not been assessed. Further 
research is warranted to examine the impact of using the model on clinical decisions, patient outcome, 
and cost-effectiveness of care, compared to standard trauma care. 
 
In conclusion, this study demonstrates that an individual patients risk of TIC can be reliably predicted 
from available clinical information using a Bayesian Network. This information may be used to 
support early and rational decisions on the use of damage control interventions and guide rapid and 
efficient activation of damage control resuscitation protocols, which in turn, may prevent an 
established coagulopathy and lead to improved outcomes. 
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Figure 1: Structure of the Bayesian Network predictive model. Black variable represents the 
predicted outcome. Grey (latent) variables represent the five identified causal factors, and white 
variables represent predictors associated with the causal factors. HR, Heart Rate; SBP, Systolic Blood 
Pressure; BD, Base Deficit; °C, measured temperature in degrees Celsius; Fluid, volume of 
prehospital resuscitation fluid administered; GCS, Glasgow Coma Scale; MOI, Mechanism Of Injury; 
Temp, Temperature. 
 
Figure 2: Discrimination and calibration of the trauma-induced coagulopathy (TIC) predictive model. 
The calibration plot shows the relationship between ideal (dashed line) and observed (solid line) 
predicted values in the development cohort (A) and the combined (temporal and external) validation 
cohort (B). The rug plot along the bottom demonstrates the distribution of predicted probabilities. The 
circles with 95% confidence intervals indicate observed frequencies by decile of predicted 
probability. The Receiver-Operating-Characteristic (ROC) Curves show the relationships between 
true positive and false positive TIC predictions in the development, temporal, and external validation 
cohorts (C). The forest plot compares the performance of the model at predicting TIC in the combined 
(temporal and external) validation cohort when each of the models predictors in turn was omitted as 




LIST OF SUPPLEMENTAL DIGITAL CONTENT 
 
Supplementary Digital Content 1: Table comparing baseline characteristics of 1091 injured patients 
according to their coagulation function. 
 
Supplementary Digital Content 2: Figure illustrating Kaplan-Meier estimates of the probability of 
survival for 1091 injured patients with either normal coagulation or trauma-induced coagulopathy. 
The p-value was calculated using the log-rank (Mantel-Cox) test. 
 
Supplementary Digital Content 3: Tables (2A-E) presenting the evidence supporting the causal 
structure of the trauma-induced coagulopathy prediction model. 
 
Supplementary Digital Content 4: Figure illustrating one-way sensitivity analyses of the impact 
individual predictor variables have on the models result. Analyses were performed using data from 
the development cohort. The dotted line represents the prior probability of trauma-induced 
coagulopathy in the development population. 
 
Supplementary Digital Content 5: Figure illustrating the Area under the Receiver Operating 
Characteristic (ROC) curve with 95% Confidence Intervals for trauma-induced coagulopathy 
predictions in 491 injured patients (combined validation cohort) using individual predictors and the 
full predictive model. The area under the ROC curve was calculated for each continuous and ordinal 
predictor in the model. 
 
Supplementary Digital Content 6: Figure illustrating the Odds Ratios with 95% Confidence 
Intervals (CI) for trauma-induced coagulopathy in 491 injured patients (combined validation cohort), 
according to individual predictors and the full predictive model. An Odds Ratio was calculated for 
each binary predictor in the model. The full model was operated at the threshold that achieved 90 
 22 
percent sensitivity for trauma-induced coagulopathy in the development cohort. FAST, Focused 
Assessment with Sonography for Trauma; MOI, Mechanism Of Injury. 
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(N = 118) 
Age – years (range) <1 35 (16 – 95) 38 (16 – 93) 45 (16 – 92)§ 
Gender - male 0 486 (81.0) 309 (82.8) 78 (66.1)§ 
Mechanism of Injury - Blunt 0 475 (79.2) 299 (80.2) 116 (98.3)§ 
Pre-Hospital fluid (ml) <1 0 (0 – 500) 0 (0 – 100) 100 (0 – 350) 
Primary Survey:     
Respiratory Rate (bpm)* 1.3 20 (16 – 24) 18 (15 – 20)§ 17 (14 – 22) 
Heat Rate (bpm) <1 95 (76 – 118) 87 (75 – 104)§ 84 (74 – 108)§ 
Systolic Blood Pressure (mmHg) 1.9 130 (107 – 148) 134 (116 – 149) 136 (114 – 150) 
Body Temperature (°C) 39.8 35.8 (35.1 – 36.5)  36.1 (35.7 – 36.7)§ 36.0 (35.3 – 36.6) 
Glasgow Coma Scale* <1 15 (11 – 15) 15 (13 – 15)§ 15 (10 – 15) 
Suspected Haemothorax <1 89 (14.9) 49 (13.2) 13 (11.1) 
Suspected unstable pelvic fracture <1 58 (9.7) 31 (8.3) 23 (20)§ 
Suspected long bone fracture <1 132 (22.2) 89 (23.9) 28 (24.4) 
FAST - Positive <1 49 (8.2) 26 (7.0) 15 (12.7) 
Baseline Blood Gas Analysis:     
pH 5.2 7.35 (7.30 – 7.40) 7.36 (7.31 – 7.39) 7.34 (7.25 – 7.39) 
Lactate 6.2 2.1 (1.3 – 3.6) 2.3 (1.4 – 3.5) 2.6 (1.6 – 3.5) 
Base Deficit 5.6 1.8 (-0.2 – 4.4) 0.6 (-1.5 – 3.3)§ 1.6 (-0.7 – 5.1) 
Baseline Thromboelastography:     
EXTEM CA5 (mm) 7.6 44 (38 – 49) 44 (39 – 50) 46 (42 – 52)§ 
EXTEM MCF (mm) 7.6 61 (56 – 65) 63 (59 – 68)§ 63 (57 – 68)§ 
FIBTEM MCF (mm) 7.6 14 (10 – 17) 15 (11 – 20)§ 16 (11 – 20)§ 
Baseline laboratory values:     
PTr 6.1 1.1 (1.0 – 1.1) 1.1 (1.0 – 1.1)§ 1.0 (1.0 – 1.1)§ 
APTT (seconds) 7.2 23 (22 – 26) 23 (22 – 26) 27 (25 – 30)§ 
Haemoglobin (g/dL) 4.4 13.9 (12.4 – 14.9) 14.1 (12.9 – 15.0)§ 13.7 (12.2 – 14.8) 
Platelet count (x109 /L) 5.0 231 (193 – 272) 219 (182 – 264)§ 245 (209 – 288)§ 
Injury severity:     
Injury Severity Score 2.4 16 (9 – 29) 13 (5 – 25)§ 17 (9 – 29) 
Head AIS ≥ 3 2.8 173 (28.8) 89 (25.9) 33 (28.0) 
Chest AIS ≥ 3 2.8 257 (42.8) 106 (30.8)§ 50 (42.4) 
Abdomen AIS ≥ 3 3.4 62 (10.3) 44 (12.8) 15 (12.7) 
Extremity AIS ≥ 3 2.7 198 (33.0) 100 (29.1) 52 (44.1)§ 
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Outcomes:     
Trauma-Induced Coagulopathy 0 71 (11.8) 39 (10.5) 15 (12.7) 
Mortality 0 71 (11.8) 28 (7.5) § 21 (17.8) 
Data presented as number (%) or median (IQR) unless otherwise stated. 
* Admission measurement or, if patient arrived intubated, pre-hospital measurement prior to sedation and intubation. 
§  The characteristic differs significantly (p < 0.05) compared with the development cohort. 
FAST, Focused Assessment with Sonography for Trauma; CA5, Clot Amplitude at 5 minutes; MCF, Maximum Clot 
Firmness; PTr, Prothrombin Time ratio; APTT, Activated Partial Thromboplastin Time; AIS, Abbreviated Injury Score. 
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Table 2: Comparison of outcomes and resuscitation resource requirements in 1091 injured 












(95% CI) P-Value 
In-hospital mortality:      
< 24-hour 0 41 (33.1) 9 (0.9) 35.5  (17.7 – 71.3) < 0.0001 
Overall 0 67 (54.0) 53 (5.5) 9.9  (7.2 – 13.4) < 0.0001 
Emergency intervention in first 24 hours:    
Transfusion <1 114 (91.9) 193 (20.0) 4.6  (4.0 – 5.3) < 0.0001 
Massive transfusion <1 54 (43.5) 11 (1.1) 38.3  (20.6 – 71.2) < 0.0001 
DCS 4.8 67 (55.8) 31 (3.4) 16.6  (11.3 – 24.2) < 0.0001 
Length of stay (days)*      
Critical Care 0 13 (3 – 21) 0 (0 – 2) - < 0.0001 
Hospital 0 32 (19 – 50) 8 (2 – 20) - < 0.0001 
Data presented as number (%) or median (IQR). Risk Ratios are for the coagulopathic group, as compared 




Table 3: Definitions of predictor variables in the trauma-induced coagulopathy model. 
 
Predictor Variable Type of Node Definition 
Heart rate Continuous Heart rate in beats per minute 
Systolic blood pressure Continuous Systolic Blood Pressure in mmHg 
Temperature Continuous Body temperature in °C  
Haemothorax Boolean Present: Clinically suspected, based on examination or CXR 
findings. 
Absent: Not suspected 
FAST result Boolean Positive: Free peritoneal fluid identified. 
Negative: No free peritoneal fluid or investigation not clinically 
indicated. 
Unstable pelvic fracture Boolean Present: Clinically suspected, based on examination or PXR 
findings. 
Absent: Not suspected 
Long bone fracture Boolean Present: Clinically suspected fracture of femur, tibia or 
humerus. Traumatic amputation proximal to ankle or elbow. 
Absent: Not suspected 
GCS Ranked Glasgow Coma Score on admission or prior to intubation 
Lactate Continuous Admission Arterial or Venous Blood Gas Analysis 
Base Deficit Continuous Admission Arterial or Venous Blood Gas Analysis 
pH Continuous Admission Arterial or Venous Blood Gas Analysis 
Mechanism of Injury Boolean Blunt / Penetrating 
Energy Boolean High-Energy: High-velocity GSW; fall > 20 feet (6 meters); 
Pedestrian or cyclist versus vehicle > 20mph; Road Traffic 
Collision with mechanical entrapment, ejection from vehicle or 
death in same passenger compartment; Entrapment under a 
train or vehicle; Crush injury; Blast injury. 
Low-Energy: Stab; low-velocity GSW; and blunt injury excluding 
injuries above. 
Volume of fluid 
administered 
Continuous Volume of crystalloid or colloid fluid administered in ml. 




Table 4: Predictive performance measures for the trauma-induced coagulopathy model in the 







AUROC 0.93 (0.90 - 0.95) 0.96 (0.94 - 0.99) § 0.93 (0.85 - 1.0) 
Calibration slope 0.96 (0.77 - 1.15) 1.30 (0.95 - 1.65) 1.15 (0.62 - 1.68) 
Calibration intercept 0.18 (-0.15 - 0.51) 0.62 (0.18 - 1.06) 0.42 (-0.29 - 1.12) 
Hosmer-Lemeshow Statistic 9.3 (P = 0.32) 11.0 (P = 0.20) 8.7 (P = 0.37) 
Brier Score 0.06 (0.05 – 0.08) 0.05 (0.03 – 0.07) 0.06 (0.03 – 0.09) 
Brier Skill Score 0.40 (0.30 – 0.51) 0.48 (0.37 – 0.59) 0.45 (0.26 – 0.64) 
§ Performance differs significantly (p < 0.05) compared with the development cohort. 
AUROC, Area Under the Receiver Operating Characteristic Curve. 
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Table 5: Comparison of key steps in model development and validation, and associated Risk of Bias 
(ROB), for existing Trauma Induced Coagulopathy (TIC) prediction models and the TIC Bayesian 
network. 
 Cosgriff 47 COAST 48 PACT 49 TIC-BN Risk of Bias (ROB)a associated with each methodological 
step (adapted from the PROBAST ROB tool 51) 
Model development      
Outcome      
Definition PT > 2x normal and 
PTT > 2x normal 
INR > 1.5 or  
aPTT > 60 sec 
INR > 1.5 INR > 1.2 and  
E-M clustering b 
Expert consensus c 
Conventional coagulation tests, such as PT, aPTT, and INR, 
have important limitations when used to estimate TIC and 
may result in errors in outcome classification. Errors in 
outcome classification can bias performance estimates.  
Clinical relevance Not assessed Assessed Assessed Assessed No matter how accurate a predictive model, it will have 
little clinical value if it is not developed to predict a relevant 
patient outcome.  
Participants      
Data source Transfusion registry 
(SC) 
Trauma registry (SC) Trauma registry (MC) Prospective cohort 
study (MC) 
High ROB when models are derived from existing registry or 
retrospective datasets. Low ROB when development data is 
collected as part of a prospective cohort study.  
Sample size (n)  58 1680 1963 600 High ROB when models are derived form small datasets. 








adults (died/ surgery/ 
ITU) 
Adult trauma patients 
who meet local 
criteria for trauma 
team activation 
High ROB if study participants are not representative of the 
target population. 
Predictors      














High ROB when predictors are selected on the basis of 
univariable analysis prior to multivariable modeling. Low 
ROB when selection is based on existing knowledge of 
established predictors. 
 
Number of predictors 4 5 6 14  
Handling of continuous 
predictors 
Dichotomized Categorized Dichotomized No conversion High ROB when continuous predictors are dichotomized or 
categorized. 
Available at time model 
intended for use? 
No Yes Yes Yes High ROB if predictors are unlikely to be available at the 
time the model is intended for use. 
Prediction model      
Model/Algorithm type Logistic regression Simple score Weighted score Bayesian Network Simple scores and algorithms may not be sufficiently 
powerful to accurately predict complex pathophysiological 
processes. 
Handling of missing data 
during parameter 
learning 
Unclear Exclusion of cases 
with missing data 
Multiple imputation  
 
No exclusions High ROB when cases with missing data are omitted from 
analysis. 
Ability of model to 
handle missing predictor 
information? 
No No No Yes Missing predictor information is common in real-world 
cases and may significantly compromise model 
performance. 
Validation of Predictive Performance 
Discrimination Not assessed AUROC (I,T,E) AUROC (I,E) AUROC (I,T,E) 
Brier Scored (I,T,E) 
Brier Skill Scored (I,T,E) 
High ROB if both discrimination and calibration are not 
evaluated. 
Calibration Not assessed Hosmer-Lemeshow 
test (T,E) 
Calibration plot (E) 
Hosmer-Lemeshow 
test (I,E) 





High ROB if both discrimination and calibration are not 
evaluated. 
Hosmer-Lemeshow test has limited power to asses poor 





a Risk of bias occurs when shortcomings in study design, conduct, or analysis could lead to systematically distorted estimates of a model’s predictive performance. b Expectation-Maximization 
clustering using individual clinical, laboratory and thromboelastometry information. c  Expert consensus of outcome classification in cases with discrepancy between laboratory and clustering 
methods. d Brier Score and Brier Skill Score are measures of overall predictive performance that combine features of discrimination and calibration to measure how close, on average, 
predicted outcomes are to actual outcomes. (SC), Single Centre; (MC), Multicentre; PT, Prothrombin Time; PTT, Partial Thromboplastin Time; aPTT, activated Partial Thromboplastin Time; INR, 
International Normalised Ratio; E-M, Expectation-Maximization; ISS, Injury Severity Score; ITU, Intensive Treatment Unit; AUROC, Area Under the Receiver Operating Characteristic curve; (I), 
Internal validation; (T), Temporal validation; (E), External validation 
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